[go: up one dir, main page]

BE904724A - Derives de piperazine 1,4-disubstitues, composition pharmaceutique les contenant; leur procede d'obtention. - Google Patents

Derives de piperazine 1,4-disubstitues, composition pharmaceutique les contenant; leur procede d'obtention.

Info

Publication number
BE904724A
BE904724A BE0/216623A BE216623A BE904724A BE 904724 A BE904724 A BE 904724A BE 0/216623 A BE0/216623 A BE 0/216623A BE 216623 A BE216623 A BE 216623A BE 904724 A BE904724 A BE 904724A
Authority
BE
Belgium
Prior art keywords
obtaining
pharmaceutical composition
composition containing
piperazine derivatives
disubstituted piperazine
Prior art date
Application number
BE0/216623A
Other languages
English (en)
French (fr)
Inventor
James Stewart New
Joseph P Yevick
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE904724A publication Critical patent/BE904724A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE0/216623A 1985-05-06 1986-05-05 Derives de piperazine 1,4-disubstitues, composition pharmaceutique les contenant; leur procede d'obtention. BE904724A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06

Publications (1)

Publication Number Publication Date
BE904724A true BE904724A (fr) 1986-11-05

Family

ID=24938510

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216623A BE904724A (fr) 1985-05-06 1986-05-05 Derives de piperazine 1,4-disubstitues, composition pharmaceutique les contenant; leur procede d'obtention.

Country Status (25)

Country Link
JP (1) JPH0753728B2 (xx)
KR (1) KR940000829B1 (xx)
CN (1) CN1017901B (xx)
AT (1) AT398572B (xx)
AU (1) AU593244B2 (xx)
BE (1) BE904724A (xx)
CA (1) CA1278792C (xx)
CH (1) CH672787A5 (xx)
DE (1) DE3615180C2 (xx)
DK (1) DK165745C (xx)
EG (1) EG18206A (xx)
ES (6) ES8801250A1 (xx)
FI (1) FI85484C (xx)
FR (1) FR2581385B1 (xx)
GB (1) GB2174703B (xx)
GR (1) GR861149B (xx)
HU (1) HU195509B (xx)
IE (1) IE59201B1 (xx)
IT (1) IT1208607B (xx)
LU (1) LU86421A1 (xx)
MY (1) MY100777A (xx)
NL (1) NL8601146A (xx)
PT (1) PT82523B (xx)
SE (1) SE465270B (xx)
ZA (1) ZA862046B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
SI0850235T1 (en) * 1995-09-15 2000-04-30 Sanofi-Synthelabo Quinolein-2(1h)-one derivatives as serotonin antagonists
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
FR2581385B1 (fr) 1991-10-04
DK165745C (da) 1993-06-14
PT82523A (en) 1986-06-01
PT82523B (pt) 1988-10-14
ES8802149A1 (es) 1988-04-01
KR860009008A (ko) 1986-12-19
CA1278792C (en) 1991-01-08
DE3615180C2 (de) 1996-03-07
DE3615180A1 (de) 1986-11-06
ES557855A0 (es) 1989-05-16
JPS61268681A (ja) 1986-11-28
ES557809A0 (es) 1988-09-01
IT8620313A0 (it) 1986-05-06
ES554659A0 (es) 1987-12-16
ES557757A0 (es) 1988-04-01
GB8610810D0 (en) 1986-06-11
CN1017901B (zh) 1992-08-19
HU195509B (en) 1988-05-30
EG18206A (en) 1992-09-30
ES8802614A1 (es) 1988-09-01
AU5679586A (en) 1986-11-13
FI85484C (fi) 1992-04-27
MY100777A (en) 1991-02-14
ES557839A0 (es) 1989-01-16
DK207186A (da) 1986-11-07
CH672787A5 (xx) 1989-12-29
FI861820A0 (fi) 1986-04-30
SE8602061D0 (sv) 1986-05-05
ES9000005A1 (es) 1989-11-01
GB2174703A (en) 1986-11-12
NL8601146A (nl) 1986-12-01
DK165745B (da) 1993-01-11
ES8900138A1 (es) 1989-01-16
KR940000829B1 (ko) 1994-02-02
ES8801250A1 (es) 1987-12-16
SE465270B (sv) 1991-08-19
FI85484B (fi) 1992-01-15
CN86103071A (zh) 1987-03-18
ATA121486A (de) 1994-05-15
HUT43848A (en) 1987-12-28
IE59201B1 (en) 1994-01-26
JPH0753728B2 (ja) 1995-06-07
ES8900253A1 (es) 1989-05-16
AU593244B2 (en) 1990-02-08
FI861820A7 (fi) 1986-11-07
GR861149B (en) 1986-09-09
IE861193L (en) 1986-11-06
SE8602061L (sv) 1986-11-07
DK207186D0 (da) 1986-05-05
LU86421A1 (fr) 1986-12-05
ZA862046B (en) 1986-11-26
GB2174703B (en) 1988-10-26
FR2581385A1 (fr) 1986-11-07
AT398572B (de) 1994-12-27
IT1208607B (it) 1989-07-10

Similar Documents

Publication Publication Date Title
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
BE904724A (fr) Derives de piperazine 1,4-disubstitues, composition pharmaceutique les contenant; leur procede d'obtention.
FR2371437A1 (fr) Nouveaux derives de pipepidine ou de morpholine utiles comme medicaments et comme fongicides
PT91121A (pt) Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas que os contem
FR2453133A1 (fr) Nouveaux acides acetohydroxamiques, leur procede de preparation et leur application en therapeutique
DE3574702D1 (de) Antitumor-platin-komplexe.
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2357556A1 (fr) Procede de transformation de cis-hexahydrodibenzo(b,d) pyran-9-ones en trans-hexahydrodibenzo(b,d) pyran-9-ones
FR2375187A1 (fr) Cyclopentane-1-amines, procede pour leur preparation et produits contenant ces composes
FR2403989A1 (fr) Nouveaux derives a-halogenomethyles d'amines utiles comme medicaments et procedes de leur preparation
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
HU906360D0 (en) Process for producing quinoline derivatives and pharmaceutical preparatives containing such compounds
FR2372818A1 (fr) Acide 5-(hydroxy (substitue) methyl)-2,3-dihydrobenzofuran-2-carboxylique et ses derives utiles comme medicaments
FR2363559A1 (fr) Nouveaux derives de perhydro-aza-heterocycles utiles comme medicaments et procede pour leur preparation
FR2403330A1 (fr) Nouveaux derives de benzoyl-2-chloro-4-glycinanilides substitues, leur procede de preparation et leur application en tant que medicaments
FR2369287A1 (fr) Procede de preparation de derives organiques d'etain d'esters mercaptoalcooliques
DK183789A (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
FI870090A0 (fi) Laongkedjade alkylresorcinolfosfiter.
FR2371460A1 (fr) Procede de preparation de kanamycine c et de ses derives desoxy
FR2453162A1 (fr) Procede pour la preparation de derives de 4-acetoxy-azetidine-2-one par condensation avec un b-thiocetoester et composes obtenus
BE905654A (fr) Derives de la armstrong 2-1,2,4-triazoline-5-one, procede pour leur preparation et leurs utilisations.
BE904588A (fr) (-)-1Beta-ETHYL-1ALPHA-HYDROXYMETHYL-1,2,3,4,6,7,12,12beta alpha-OCTAHYDROINDOLO (2,3-a) QUINOLIZINE, PROCEDE POUR LA PREPARER ET COMPOSITIONS PHARMACEUTIQUES CONTENANT CELLE-CI.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BRISTOL-MYERS CY

Effective date: 20060505